mRNA vaccines ka concept naya lagta hai, par yeh bas humare sharir ke khud ke cell machinery ko sikhata hai ki virus ka nakli spike protein kaise banaye — jisse immunity develop ho, bina live virus ke. Bharat mein yeh bahut mahatvapurna hai kyunki yeh jaldi tailor kiye ja sakte hain naye variants ke liye, aur scale-up mein zyada samay nahin lagta. Lekin regulator ki nazar mein, nayi technology ke liye humara risk-assessment aur cold-chain ki kadi dekhbhal zaroori hai... jaisa mere pitaji ke PPS dukaan ka stock register hota hai, har vial ki movement track karni padti hai, taaki bharosa rahe.
#work#career
Jump in to reply — no account needed.